Skip to main content

Nephros, Inc.

corporate_fare Company Profile

Nephros, Inc.

NEPH·NASDAQ·Industrial Applications And Services·CIK 0001196298

Nephros is a commercial-stage company that develops and markets high-performance water filtration solutions for points of use, primarily focusing on medical-grade water filtration. Its medical filtration portfolio includes two product lines: infection control and dialysis water. The infection control segment offers microfilters (0.1 micron), which retain bacteria, and ultrafilters (0.005 micron), which retain bacteria, viruses, and endotoxins, addressing waterborne pathogens such as Legionella and Pseudomonas. The dialysis segment exclusively uses ultrafilters, providing microbial and endotoxin retention for water and bicarbonate concentrate used in dialysis treatment, where endotoxin control is critical. All medical-grade filters are FDA 510(k)-cleared as Class II medical devices. These filters are used in healthcare settings and other industries including manufacturing, laboratories, aviation, and federal facilities. Additionally, Nephros offers commercial water filters that improve taste and odor, reduce biofilm formation and scale buildup, and remove cysts, particulates, and lead. A new solution has been released, validated for the reduction of Total PFAS (a mixture of seven PFAS compounds including PFOA, PFOS, PFHxS, PFNA, PFHpA, PFBS, and PFDA), enhancing the portfolio's ability to address emerging and persistent waterborne contaminants. Commercial filtration products are applicable across industries and can be used with medical-grade filters for comprehensive water-quality protection. For medical applications, Nephros manufactures ultra- and microfilters using polysulfone hollow fiber membranes that retain microbiological contaminants through physical size exclusion.

Nephros, Inc. (NASDAQ:NEPH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 11 items for NEPH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 11 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for NEPH spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • Q3 Revenue Climbs 18% to $5.6M as Nephros Stays Profitable
  • Nephros Q3 2026: Revenue Up 18% to $5.6M, Net Income $0.5M
  • Nephros Q3 10-Q: Profit Holds, But Material Weakness Keeps Controls 'Not Effective'
  • Nephros Q2 Revenue Surges 36% to $6M, Net Income Hits $1.2M, but Material Weakness Lingers
  • Nephros Q2 Revenue Surges 36%, Beats Estimates by 20%

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$18.79M
Net Income
$1.19M
Diluted EPS
$0.11
Op. Cash Flow
$1.65M
Gross Profit
$11.63M
Operating Income
$1.15M
Cash & Equivalents
$5.4M
Debt / Equity
0.00×
Net Margin
6.4%
Shares Outstanding
10.64M sh
Source: 10-K · filed 2026-04-30 · accession 0001493152-26-020416

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 11,913 shares in NEPH as of the October 30, 2026 settlement, a 22.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 19, 2026, 60.7% of NEPH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)11,913 shares as of October 30, 2026
Change vs prior period▼ 22.8%
Days to cover1.00 at avg daily volume of 54,291
Daily short volume (FINRA facilities)60.7% of 11,826 shares on November 19, 2026
5-day average short volume49.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with N →
$2.72 -4.26% today
52-week range · as of 2026-11-05 $2.66 – $6.42
Market cap
$29.56M
Volume
40.1K (0.6× avg)
3-mo avg 65.2K
Live data · 2026-11-20 20:49 UTC · Market open

show_chartPrice Chart

Loading chart...

feed NEPH - Latest Insights

NEPH
Nov 05, 2026, 4:10 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.09
Real-time Price: $2.72 info
Change: -$0.371 (-12%) info
Market Cap: $29.556M info
NEPH
Nov 05, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.09
Real-time Price: $2.72 info
Change: -$0.371 (-12%) info
Market Cap: $29.556M info
NEPH
Nov 05, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.09
Real-time Price: $2.72 info
Change: -$0.371 (-12%) info
Market Cap: $29.556M info
NEPH
Aug 10, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.38
Real-time Price: $2.72 info
Change: -$1.66 (-38%) info
Market Cap: $29.556M info
NEPH
Aug 06, 2026, 4:44 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $4.22
Real-time Price: $2.72 info
Change: -$1.50 (-36%) info
Market Cap: $29.556M info
NEPH
May 07, 2026, 4:58 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.01
Real-time Price: $2.72 info
Change: -$0.291 (-10%) info
Market Cap: $29.556M info
NEPH
May 07, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.01
Real-time Price: $2.72 info
Change: -$0.291 (-10%) info
Market Cap: $29.556M info
NEPH
Apr 16, 2026, 9:57 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.12
Real-time Price: $2.72 info
Change: -$0.401 (-13%) info
Market Cap: $29.556M info
NEPH
Apr 01, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.98
Real-time Price: $2.72 info
Change: -$0.261 (-9%) info
Market Cap: $29.556M info
NEPH
Mar 27, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.89
Real-time Price: $2.72 info
Change: -$0.171 (-6%) info
Market Cap: $29.556M info
NEPH
Mar 12, 2026, 4:01 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.80
Real-time Price: $2.72 info
Change: -$1.08 (-28%) info
Market Cap: $29.556M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets